Prognostic Value of Monitoring Tumour Markers CA 15-3 and CEA During Fulvestrant Treatment
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-6-81
Full Text
Open PDFAbstract
Available in full text
Date
March 26, 2006
Authors
Publisher
Springer Nature